“We appreciate the opportunity to continue our discussion with the FDA during a public hearing about the use of Avastin in metastatic breast cancer,” said Hal Barron, M.D., chief medical officer and head, Global Product Development. …
Excerpt from:
The Medical Quack: FDA Grants Genentech (Roche) a Hearing on …
No Comments Yet - be the First!